Project Professor, AXA Department of Health and Human Security / M.D., Ph.D., M.S.
Areas of interest
Publications Click here contact firstname.lastname@example.org
Descriptive and analytic epidemiology of cancer, population-based study, cancer registry methodology, cancer prevention, systematic reviews, meta-analysis, pooled analysis, cohort consortium, preventive medicine
Project Professor, AXA Department of Health and Human Security, Graduate School of Medicine, The University of Tokyo
Section Head, Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center
Epidemiology and Biostatistics Division, National Cancer Center Research Institute East (concurrent)
Senior Research Scientist, National Cancer Center Research Institute
Aichi-Prefectural Cancer Registry, Aichi Prefectural Government (concurrent)
Senior Research Scientist, Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute
Research Scientist, Division of Epidemiology, Aichi Cancer Center Research Institute
M.S. in Epidemiology, Harvard University School of Public Health
Ph.D., Nagoya University
M.D., School of Medicine, University of Tsukuba
Svensson T, Yamaji T, Budhathoki S, Hidaka A, Iwasaki M, Sawada N, et al. Alcohol consumption, genetic variants in the alcohol- and folate metabolic pathways and colorectal cancer risk: the JPHC Study.Scientific Reports. 2016;6:36607.
Saito I, Yamagishi K, Kokubo Y, Yatsuya H, Iso H, Sawada N, et al. Association between mortality and incidence rates of coronary heart disease and stroke: The Japan Public Health Center-based prospective (JPHC) study. International Journal of Cardiology. 2016; 222:281-6.
Lin Y, Totsuka Y, Shan B, Wang C, Wei W, Qiao Y, et al. Esophageal cancer in high-risk areas of China: research progress and challenges. Annals of Epidemiology. Online first.
Inoue M. Changing epidemiology of Helicobacter pylori in Japan. Gastric Cancer. Online First.
GBD 2015 Risk Factors Collaborators. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1659-1724.
GBD 2015 DALYS and HALE Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1603-1658.
GBD 2015 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016;388(10053):1545-1602.
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet. 2016; 388(10053): 1459-1544.
Kondo H, Soda M, Sawada N, Inoue M, Imaizumi Y, Miyazaki Y, et al. Smoking is a risk factor for development of adult T-cell leukemia/lymphoma in Japanese human T-cell leukemia virus type-1 carriers. Cancer Causes and Control. 2016; 27(9): 1059-1066.
Akter S, Kashino I, Mizoue T, Matsuo K, Ito H, Wakai K, et al.Coffee drinking and colorectal cancer risk: an evaluation based on a systematic review and meta-analysis among the Japanese population. Japanese Journal of Clinical Oncology. 2016;46(8):781-7.